低危肺栓塞患者非住院管理的前瞻性研究
本研究为美国五家急诊科开展的单臂前瞻性队列管理研究,纳入200例经PESI<86、超声心动图和全腿加压超声评估为低危的急性肺栓塞患者,在急诊或医院观察>12至<24小时后转为门诊抗凝治疗。90天复合终点(全因死亡、复发性症状性VTE、大出血)发生率为0.5%(95%CI 0.02%-2.36%),无患者复发VTE或死亡,1例发生大出血,患者满意度高。结论认为经严格选择的低危肺栓塞患者非住院管理安全且可接受,但需谨慎解读。
要点
- 经PESI<86、超声心动图和全腿加压超声严格筛选的低危肺栓塞患者非住院管理安全。
- 90天复合终点发生率为0.5%(95%CI 0.02%-2.36%),无复发性VTE或死亡。
- 研究样本量小且急诊超声心动图可及性影响推广,结果需谨慎解读。
核心结论
- 经PESI<86、超声心动图和全腿加压超声严格选择的急性低危肺栓塞患者,非住院管理安全且患者可接受。
- 因样本量相对终点较小及急诊超声心动图可及性的普适性问题,结果需谨慎看待。
研究设计与样本
- 连续纳入200例客观确诊的急性肺栓塞成人患者,经PESI<86、超声心动图和全腿加压超声评估为低危。
- 主要干预为急诊或医院观察>12至<24小时,随后门诊使用FDA批准的治疗性抗凝。
主要发现
- 90天复合终点(全因死亡、复发性症状性VTE、大出血)发生率为0.5%(95%CI 0.02%-2.36%),200例中1例发生。
- 90天随访期间无患者发生复发性VTE或死亡。
- 1例患者发生大出血。
- 患者对治疗满意度高。
关键数值与推荐
- 纳入标准:客观确诊急性肺栓塞且PESI评分<86、超声心动图无右心劳损征象、全腿加压超声无腘静脉以近DVT。
- 排除标准:PESI≥86、超声心动图右心劳损征象、腘静脉以近DVT、低氧、低血压、肝或肾功能衰竭、抗凝禁忌或需住院的其他情况。
临床怎么用
- 对经PESI<86、超声心动图和全腿加压超声严格筛选的低危肺栓塞患者,可考虑急诊或医院观察>12至<24小时后转为门诊抗凝治疗。
- 实施前需确保急诊超声心动图可及性,并严格排除右心劳损、近端DVT、低氧、低血压及肝肾功能衰竭等情况。
局限性
- 样本量相对终点较小。
- 急诊超声心动图可及性影响结果的普适性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The efficacy and safety of managing patients with low-risk pulmonary embolism (PE) without hospitalization requires objective data from US medical centers. We sought to determine the 90-day composite rate of recurrent symptomatic VTE, major bleeding events, and all-cause mortality among consecutive patients diagnosed with acute low-risk PE managed without inpatient hospitalization; and to measure patient satisfaction. METHODS: We performed a prospective cohort single-arm management study conducted from January 2013 to October 2016 in five EDs. We enrolled 200 consecutive adults diagnosed with objectively confirmed acute PE and assessed to have a low risk for mortality using the Pulmonary Embolism Severity Index (PESI) score (< 86), echocardiography, and whole-leg compression ultrasound (CUS). The primary intervention was observation in the ED or hospital (observation status) for > 12 to < 24 h, followed by outpatient management with Food and Drug Administration-approved therapeutic anticoagulation. Patients were excluded for a PESI ≥ 86, echocardiographic signs of right heart strain, DVT proximal to the popliteal vein, hypoxia, hypotension, hepatic or renal failure, contraindication to therapeutic anticoagulation, or another condition requiring hospital admission. The primary outcome was 90-day composite rate of all-cause mortality, recurrent symptomatic VTE, and major bleeding. RESULTS: The composite outcome occurred in one of 200 patients (90-day composite rate = 0.5%; 95% CI, 0.02%-2.36%). No patient suffered recurrent VTE or died during the 90-day follow-up period. A major bleed occurred in one patient. Patients indicated a high level of satisfaction with their care. CONCLUSIONS: Treatment of carefully selected patients with acute PE and low risk by PESI < 86, echocardiography, and CUS without inpatient hospitalization is safe and acceptable to patients. Results must be viewed with caution because of the small sample size relative to the end point and the generalizability surrounding availability of emergent echocardiography. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT02355548; URL: www.clinicaltrials.gov.
引用
- Bledsoe JR, Woller SC, Stevens SM, et al. Management of Low-Risk Pulmonary Embolism Patients Without Hospitalization: The Low-Risk Pulmonary Embolism Prospective Management Study. Chest. 2018. PMID: 29410163. doi:10.1016/j.chest.2018.01.035
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。